Keros Therapeutics, Inc. (KROS)

19.50 +0.62 (+3.28%) USD  |  NASDAQ  |  Jan 13, 16:00
19.52 +0.02 (+0.10%) After-Hours: 20:00
More

Keros Therapeutics Buildings and Improvements (Quarterly)

Buildings and Improvements (Quarterly) Chart

View Buildings and Improvements (Quarterly) for KROS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Buildings and Improvements (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Buildings and Improvements (Quarterly) Range, Past 5 Years

View Buildings and Improvements (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Buildings and Improvements (Quarterly) Benchmarks

View Buildings and Improvements (Quarterly) Benchmarks
Start Trial
Eli Lilly & Co. --
Pfizer Inc. --
Innoviva, Inc. --
Ocugen, Inc. --
Bionano Genomics, Inc. --